Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #671 to #720.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Emergency Locator TransmitterDistress radiobeacon
  2. Emergency Position-Indicating Radio BeaconDistress radiobeacon
  3. Personal Locator BeaconDistress radiobeacon
  4. CABG Patch Cardioplegia SubstudyDoes Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
  5. Doggy positionDoggy style
  6. Domination & submission (BDSM)Dominance and submission
  7. DEBATEDoppler Endpoints Balloon Angioplasty Trial Europe
  8. DEBATE IIDoppler Endpoints Balloon Angioplasty Trial Europe-2
  9. DESTINI-CFRDoppler Endpoints Stenting International Investigation - Coronary Flow Reserve
  10. PRECISEDouble-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
  11. REFLECTDouble-Blind, Placebo-Controlled Study Of The Efficacy Of Flosequinan In Patients With Chronic Heart Failure
  12. SUTAMIDouble-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
  13. DIMTDouble-Blind Placebo-Controlled Study Of Ibopamine And Digoxin In Patients With Mild To Moderate Heart Failure: Results Of The Dutch Ibopamine Multic
  14. SAPATDouble-Blind Trial Of Aspirin In Primary Prevention Of Myocardial Infarction In Patients With Stable Chronic Angina Pectoris
  15. Dow ChemicalDow Chemical Company
  16. Dr. Reddy'sDr. Reddy's Laboratories
  17. DECLARE-DIABETESDrug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus
  18. ISAR-DESIREDrug-Eluting Stents For In-Stent Restenosis
  19. DEDICATION: Stent StudyDrug Elution And Distal Protection In Acute Myocardial Infarction
  20. DEDICATION: Distal Protection StudyDrug Elution And Distal Protection In St-Elevation Myocardial Infarction
  21. Drug Enforcement AgencyDrug Enforcement Administration
  22. United States Drug Enforcement AdministrationDrug Enforcement Administration
  23. DAVID – (Picotamide vs. Aspirin)Drug Evaluation In Atherosclerotic Vascular Disease In Diabetics
  24. Drug policyDrug policy of the United States
  25. DAVIDDual-Chamber And Vvi Implantable Defibrillator
  26. DAVID IIDual Chamber And Vvi Implantable Defibrillator II
  27. DAPPAFDual Site Atrial Pacing To Prevent Atrial Fibrillation
  28. DUCCS-1Duke University Clinical Cardiology Study - 1
  29. DUCCS-2Duke University Clinical Cardiology Study - 2
  30. DECREASE-VDutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V
  31. DECREASE IIIDutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo III
  32. DysgenicDysgenics
  33. Lipid profileDyslipidemia laboratory tests
  34. DYSBOTDysport And Botox Study
  35. E.B. FordE. B. Ford
  36. Emf balancing techniqueEMF balancing technique
  37. EmedicineEMedicine
  38. PTGER1EP1 receptor
  39. Earl W. Sutherland, Jr.Earl Wilbur Sutherland Jr.
  40. ELLDOPAEarlier Versus Later Levodopa In Parkinson Disease
  41. BHACASEarly And Midterm Outcome After Off-Pump And On-Pump Surgery In Beating Heart Against Cardioplegic Arrest Studies (Bhacas 1 And 2): A Pooled Analysis Of Two Randomised Controlled Trials.
  42. EASYEarly Discharge After Transradial Stenting Of Coronary Arteries
  43. EGASISEarly Gaba-Ergic Activation Sin Troke
  44. EARLY ACSEarly Glycoprotein IIb/IIia Inhibition In Non–St-Segment Elevation Acute Coronary Syndromes
  45. ER-TIMIEarly Retavase - Thrombolysis In Myocardial Infarction
  46. ERNAEarly Return To Normal Activities At Two Weeks After Acute Myocardial Infarction: Preliminary Results Of A Randomized Study
  47. ETROPEarly Treatment Of Retinopathy Of Prematurity
  48. EASYASEastbourne Syncope Assessment Study
  49. ECHO in PPHEchocardiographic Predictors Of Adverse Outcomes In Primary Pulmonary Hypertension.
  50. EcosystemsEcosystem

View ( | ) (20 | 50 | 100 | 250 | 500)